Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
34.07
+2.44 (7.71%)
At close: Feb 21, 2025, 4:00 PM
35.10
+1.03 (3.02%)
After-hours: Feb 21, 2025, 7:59 PM EST
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $3.80 billion as of February 21, 2025. Its market cap has increased by 54.42% in one year.
Market Cap
3.80B
Enterprise Value
2.90B
1-Year Change
54.42%
Ranking
Category
Stock Price
$34.07
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $3.80B, an increase of 4,804.92%. That is a compound annual growth rate of 48.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 3.80B | -15.33% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 787.08B |
| UnitedHealth Group | 429.49B |
| Johnson & Johnson | 391.63B |
| Novo Nordisk | 370.84B |
| AbbVie | 358.66B |
| Abbott Laboratories | 234.21B |
| AstraZeneca | 229.50B |
| Merck & Co. | 224.86B |